| | | 00646 | | 10.08.2000 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | | 08.08. | | | | 08.08. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Revaxis | suspension injectable | ( 20U.I. / 0.5ml, 2U.I. / 0.5ml) | J07CA01 | | | 02 | Revaxis | | ( 0 , 0 , 0 ) | Codice | | | 03 | Revaxis | | ( 20 UI, 2 UI, 62 U) | | |
|
|
